Healthcare & Life Sciences
Curamir
series-a
series-a
Stage
1
Investors
About
Curamir is a genetic medicine platform focused on developing microRNA therapeutics for oncology.
Explore Curamir's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.